APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Traveler's Diarrhea Therapeutics

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Selected research

Industry Growth & Trends

Global Traveler's Diarrhea Therapeutics Industry Growth and Trends Forecast to 2032

Report ID 174042860119 December 202596 pages

Choose your research edition.

Industry ResearchTraveler's Diarrhea Therapeutics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Traveler's Diarrhea Therapeutics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Traveler's Diarrhea Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Traveler's Diarrhea Therapeutics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Traveler's Diarrhea Therapeutics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Traveler's Diarrhea Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Traveler's Diarrhea Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Traveler's Diarrhea Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Traveler's Diarrhea Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Traveler's Diarrhea Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Traveler's Diarrhea Therapeutics Market by Company

Salix Pharmaceuticals

P&G

Johnson & Johnson

Otsuka Pharma

Valneva

Shanghai United Cell

PaxVax

Livzon

Immuron

Traveler's Diarrhea Therapeutics Segment by Type

Immunization

Non-antibiotic Agents

Antibiotics

Anti-Motility Agents

Others

Traveler's Diarrhea Therapeutics Segment by Application

Adult Traveler's Diarrhea

Children Traveler's Diarrhea

Traveler's Diarrhea Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Traveler's Diarrhea Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Traveler's Diarrhea Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Traveler's Diarrhea Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Traveler's Diarrhea Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunization Table 2. Major Company of Non-antibiotic Agents Table 3. Major Company of Antibiotics Table 4. Major Company of Anti-Motility Agents Table 5. Major Company of Others Table 6. Global Traveler's Diarrhea Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 8. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 9. Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 10. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type (2021-2026) Table 11. Global Traveler's Diarrhea Therapeutics Price by Type (2021-2026) & (USD/Unit) Table 12. Global Traveler's Diarrhea Therapeutics Sales by Type (2027-2032) & (K Units) Table 13. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 14. Global Traveler's Diarrhea Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 15. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type (2027-2032) Table 16. Global Traveler's Diarrhea Therapeutics Price by Type (2027-2032) & (USD/Unit) Table 17. North America Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 18. North America Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 20. Europe Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 24. Latin America Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 27. Traveler's Diarrhea Therapeutics Industry Trends Table 28. Traveler's Diarrhea Therapeutics Industry Drivers Table 29. Traveler's Diarrhea Therapeutics Industry Opportunities and Challenges Table 30. Traveler's Diarrhea Therapeutics Industry Restraints Table 31. Global Traveler's Diarrhea Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2021-2026) Table 33. Global Traveler's Diarrhea Therapeutics Sales by Company (2021-2026) & (K Units) Table 34. Global Traveler's Diarrhea Therapeutics Sales Share by Company (2021-2026) Table 35. Global Traveler's Diarrhea Therapeutics Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Traveler's Diarrhea Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Traveler's Diarrhea Therapeutics Major Company Production Sites and Headquarters Table 38. Global Traveler's Diarrhea Therapeutics Company, Product Type & Application Table 39. Global Traveler's Diarrhea Therapeutics Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Traveler's Diarrhea Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Traveler's Diarrhea Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Traveler's Diarrhea Therapeutics Sales by Region (2021-2026) & (K Units) Table 44. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 45. Global Traveler's Diarrhea Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 46. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Region (2021-2026) Table 47. Global Traveler's Diarrhea Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Traveler's Diarrhea Therapeutics Sales by Region (2027-2032) & (K Units) Table 49. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 50. Global Traveler's Diarrhea Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 51. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Region (2027-2032) Table 52. Global Traveler's Diarrhea Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Traveler's Diarrhea Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 55. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 56. Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 57. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application (2021-2026) Table 58. Global Traveler's Diarrhea Therapeutics Price by Application (2021-2026) & (USD/Unit) Table 59. Global Traveler's Diarrhea Therapeutics Sales by Application (2027-2032) & (K Units) Table 60. Global Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 61. Global Traveler's Diarrhea Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 62. Global Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application (2027-2032) Table 63. Global Traveler's Diarrhea Therapeutics Price by Application (2027-2032) & (USD/Unit) Table 64. North America Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 65. North America Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 67. Europe Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 71. Latin America Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 74. Salix Pharmaceuticals Company Information Table 75. Salix Pharmaceuticals Business Overview Table 76. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio Table 78. Salix Pharmaceuticals Recent Development Table 79. P&G Company Information Table 80. P&G Business Overview Table 81. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. P&G Traveler's Diarrhea Therapeutics Product Portfolio Table 83. P&G Recent Development Table 84. Johnson & Johnson Company Information Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio Table 88. Johnson & Johnson Recent Development Table 89. Otsuka Pharma Company Information Table 90. Otsuka Pharma Business Overview Table 91. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio Table 93. Otsuka Pharma Recent Development Table 94. Valneva Company Information Table 95. Valneva Business Overview Table 96. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Valneva Traveler's Diarrhea Therapeutics Product Portfolio Table 98. Valneva Recent Development Table 99. Shanghai United Cell Company Information Table 100. Shanghai United Cell Business Overview Table 101. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio Table 103. Shanghai United Cell Recent Development Table 104. PaxVax Company Information Table 105. PaxVax Business Overview Table 106. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. PaxVax Traveler's Diarrhea Therapeutics Product Portfolio Table 108. PaxVax Recent Development Table 109. Livzon Company Information Table 110. Livzon Business Overview Table 111. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Livzon Traveler's Diarrhea Therapeutics Product Portfolio Table 113. Livzon Recent Development Table 114. Immuron Company Information Table 115. Immuron Business Overview Table 116. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Immuron Traveler's Diarrhea Therapeutics Product Portfolio Table 118. Immuron Recent Development Table 119. North America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. North America Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 121. North America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2026) Table 122. North America Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 123. North America Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 124. North America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Traveler's Diarrhea Therapeutics Market Share by Country (2021-2026) Table 127. North America Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Traveler's Diarrhea Therapeutics Market Share Forecast by Country (2027-2032) Table 129. Europe Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Europe Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 131. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2026) Table 132. Europe Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 133. Europe Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Traveler's Diarrhea Therapeutics Market Share by Country (2021-2026) Table 137. Europe Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Traveler's Diarrhea Therapeutics Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 141. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 143. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Traveler's Diarrhea Therapeutics Market Share by Country (2021-2026) Table 147. Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Traveler's Diarrhea Therapeutics Market Share Forecast by Country (2027-2032) Table 149. Latin America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Latin America Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 151. Latin America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2026) Table 152. Latin America Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 153. Latin America Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Traveler's Diarrhea Therapeutics Market Share by Country (2021-2026) Table 157. Latin America Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Traveler's Diarrhea Therapeutics Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 161. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 163. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Traveler's Diarrhea Therapeutics Market Share by Country (2021-2026) Table 167. Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Traveler's Diarrhea Therapeutics Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Traveler's Diarrhea Therapeutics Distributors List Table 172. Traveler's Diarrhea Therapeutics Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Traveler's Diarrhea Therapeutics Image Figure 2. Global Traveler's Diarrhea Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Traveler's Diarrhea Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Traveler's Diarrhea Therapeutics Sales (2021-2032) & (K Units) Figure 5. Immunization Image Figure 6. Global Immunization Sales YoY Growth (2021-2032) & (K Units) Figure 7. Non-antibiotic Agents Image Figure 8. Global Non-antibiotic Agents Sales YoY Growth (2021-2032) & (K Units) Figure 9. Antibiotics Image Figure 10. Global Antibiotics Sales YoY Growth (2021-2032) & (K Units) Figure 11. Anti-Motility Agents Image Figure 12. Global Anti-Motility Agents Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Traveler's Diarrhea Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Traveler's Diarrhea Therapeutics Market Share by Type 2025 VS 2032 Figure 17. North America Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. North America Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Europe Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Europe Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type in 2025 Figure 23. Latin America Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Traveler's Diarrhea Therapeutics Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Adult Traveler's Diarrhea Image Figure 30. Global Adult Traveler's Diarrhea Sales YoY Growth (2021-2032) & (K Units) Figure 31. Children Traveler's Diarrhea Image Figure 32. Global Children Traveler's Diarrhea Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Traveler's Diarrhea Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Traveler's Diarrhea Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application in 2025 Figure 36. North America Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application in 2025 Figure 37. Europe Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share in Value by Application in 2025 Figure 45. North America Traveler's Diarrhea Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Traveler's Diarrhea Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Traveler's Diarrhea Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Traveler's Diarrhea Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Traveler's Diarrhea Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Traveler's Diarrhea Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Traveler's Diarrhea Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Traveler's Diarrhea Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Traveler's Diarrhea Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Traveler's Diarrhea Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Traveler's Diarrhea Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Traveler's Diarrhea Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Traveler's Diarrhea Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Traveler's Diarrhea Therapeutics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Traveler's Diarrhea Therapeutics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immunization
  • Non-antibiotic Agents
  • Antibiotics
  • Anti-Motility Agents
  • Others
Applications
  • Adult Traveler's Diarrhea
  • Children Traveler's Diarrhea
Companies covered
  • Salix Pharmaceuticals
  • P&G
  • Johnson & Johnson
  • Otsuka Pharma
  • Valneva
  • Shanghai United Cell
  • PaxVax
  • Livzon
  • Immuron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Traveler's Diarrhea Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Traveler's Diarrhea Therapeutics Market by Type
  6. 1.3.1 Immunization
  7. 1.3.2 Non-antibiotic Agents
  8. 1.3.3 Antibiotics
  9. 1.3.4 Anti-Motility Agents
  10. 1.3.5 Others
  11. 1.4 Global Traveler's Diarrhea Therapeutics Market Size by Type
  12. 1.4.1 Global Traveler's Diarrhea Therapeutics Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Traveler's Diarrhea Therapeutics Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Traveler's Diarrhea Therapeutics Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Traveler's Diarrhea Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Traveler's Diarrhea Therapeutics Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Traveler's Diarrhea Therapeutics Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Traveler's Diarrhea Therapeutics Industry Trends
  2. 2.2 Traveler's Diarrhea Therapeutics Industry Drivers
  3. 2.3 Traveler's Diarrhea Therapeutics Industry Opportunities and Challenges
  4. 2.4 Traveler's Diarrhea Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Traveler's Diarrhea Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by Traveler's Diarrhea Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by Traveler's Diarrhea Therapeutics Price (2021-2026)
  4. 3.4 Global Traveler's Diarrhea Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Traveler's Diarrhea Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global Traveler's Diarrhea Therapeutics Company, Product Type & Application
  7. 3.7 Global Traveler's Diarrhea Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Traveler's Diarrhea Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Traveler's Diarrhea Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Traveler's Diarrhea Therapeutics Tier 1, Tier 2, and Tier 3
4 Traveler's Diarrhea Therapeutics Regional Status and Outlook
  1. 4.1 Global Traveler's Diarrhea Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Traveler's Diarrhea Therapeutics Historic Market Size by Region
  3. 4.2.1 Global Traveler's Diarrhea Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Traveler's Diarrhea Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Traveler's Diarrhea Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Traveler's Diarrhea Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global Traveler's Diarrhea Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Traveler's Diarrhea Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Traveler's Diarrhea Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Traveler's Diarrhea Therapeutics by Application
  1. 5.1 Traveler's Diarrhea Therapeutics Market by Application
  2. 5.1.1 Adult Traveler's Diarrhea
  3. 5.1.2 Children Traveler's Diarrhea
  4. 5.2 Global Traveler's Diarrhea Therapeutics Market Size by Application
  5. 5.2.1 Global Traveler's Diarrhea Therapeutics Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Traveler's Diarrhea Therapeutics Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Traveler's Diarrhea Therapeutics Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Traveler's Diarrhea Therapeutics Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Traveler's Diarrhea Therapeutics Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Traveler's Diarrhea Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Salix Pharmaceuticals
  2. 6.1.1 Salix Pharmaceuticals Company Information
  3. 6.1.2 Salix Pharmaceuticals Business Overview
  4. 6.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio
  6. 6.1.5 Salix Pharmaceuticals Recent Developments
  7. 6.2 P&G
  8. 6.2.1 P&G Company Information
  9. 6.2.2 P&G Business Overview
  10. 6.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio
  12. 6.2.5 P&G Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Otsuka Pharma
  20. 6.4.1 Otsuka Pharma Company Information
  21. 6.4.2 Otsuka Pharma Business Overview
  22. 6.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio
  24. 6.4.5 Otsuka Pharma Recent Developments
  25. 6.5 Valneva
  26. 6.5.1 Valneva Company Information
  27. 6.5.2 Valneva Business Overview
  28. 6.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio
  30. 6.5.5 Valneva Recent Developments
  31. 6.6 Shanghai United Cell
  32. 6.6.1 Shanghai United Cell Company Information
  33. 6.6.2 Shanghai United Cell Business Overview
  34. 6.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio
  36. 6.6.5 Shanghai United Cell Recent Developments
  37. 6.7 PaxVax
  38. 6.7.1 PaxVax Company Information
  39. 6.7.2 PaxVax Business Overview
  40. 6.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio
  42. 6.7.5 PaxVax Recent Developments
  43. 6.8 Livzon
  44. 6.8.1 Livzon Company Information
  45. 6.8.2 Livzon Business Overview
  46. 6.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio
  48. 6.8.5 Livzon Recent Developments
  49. 6.9 Immuron
  50. 6.9.1 Immuron Company Information
  51. 6.9.2 Immuron Business Overview
  52. 6.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio
  54. 6.9.5 Immuron Recent Developments
7 North America by Country
  1. 7.1 North America Traveler's Diarrhea Therapeutics Sales by Country
  2. 7.1.1 North America Traveler's Diarrhea Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Traveler's Diarrhea Therapeutics Market Size by Country
  6. 7.2.1 North America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Traveler's Diarrhea Therapeutics Sales by Country
  2. 8.1.1 Europe Traveler's Diarrhea Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Traveler's Diarrhea Therapeutics Market Size by Country
  6. 8.2.1 Europe Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Traveler's Diarrhea Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Traveler's Diarrhea Therapeutics Sales by Country
  2. 10.1.1 South America Traveler's Diarrhea Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Traveler's Diarrhea Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Traveler's Diarrhea Therapeutics Market Size by Country
  6. 10.2.1 South America Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Traveler's Diarrhea Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Traveler's Diarrhea Therapeutics Value Chain Analysis
  2. 12.1.1 Traveler's Diarrhea Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Traveler's Diarrhea Therapeutics Production Mode & Process
  7. 12.2 Traveler's Diarrhea Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Traveler's Diarrhea Therapeutics Distributors
  10. 12.2.3 Traveler's Diarrhea Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst